Physician profile
Goran Rac
NPI 1104271980
$1,881.41
in general payments reported to CMS, 2019-2025
24 companies · $328 in 2025
The $328 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2021: $193 · 2022: $368 · 2023: $354 · 2024: $441 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,123.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $646.82 | 2019-2023 | |
| Olympus America INC. | $178.75 | 2022-2025 | Itind System |
| Travere Therapeutics, INC. | $117.14 | 2019 | |
| Calyxo, INC. | $113.81 | 2024 | Cvac Aspiration System |
| Urovant Sciences INC | $113.69 | 2022 | |
| Sumitomo Pharma America, INC. | $103.45 | 2023-2025 | Orgovyx, Gemtesa |
| Intuitive Surgical, INC. | $98.32 | 2024 | |
| Innovation Technologies INC | $64.53 | 2024-2025 | Irrisept |
| Merck Sharp & Dohme LLC | $55.48 | 2024-2025 | Keytruda, Welireg |
| Progenics Pharmaceuticals, INC. | $48.55 | 2023-2025 | Pylarify |
| Astellas Pharma US INC | $39.82 | 2022 | |
| Urogen Pharma, INC. | $37.21 | 2024 | |
| Ferring Pharmaceuticals INC. | $36.09 | 2024-2025 | Adstiladrin |
| Abbvie INC. | $33.06 | 2025 | |
| Endo USA, INC. | $31.78 | 2025 | Aveed, Xiaflex |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $21.78 | 2023 | |
| Pfizer INC. | $21.75 | 2023 | |
| Myovant Sciences INC. | $21.57 | 2022 | |
| Ambu INC. | $21.00 | 2025 | |
| Janssen Biotech, INC. | $18.18 | 2025 | Erleada |
| Cook Medical LLC | $16.83 | 2024 | Ncircle |
| Procept Biorobotics Corporation | $15.23 | 2024 | Aquabeam System |
| Coloplast Corp | $14.32 | 2025 | |
| Laborie Medical Technologies Corp. | $12.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Goran Rac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.